home / stock / renx / renx quote
Last: | $ |
---|---|
Change Percent: | -2.66% |
Open: | $21.49 |
Close: | $21.19 |
High: | $21.55 |
Low: | $21.18 |
Volume: | 547,934 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $21.49 | $21.19 | $21.55 | $21.18 | 547,934 | 09-07-2018 |
$ | $21.99 | $21.77 | $22.05 | $21.76 | 110,545 | 09-06-2018 |
$ | $22.03 | $21.92 | $22.05 | $21.89 | 76,521 | 09-05-2018 |
$ | $22.07 | $22.22 | $22.22 | $21.98 | 127,405 | 09-04-2018 |
$ | $22.32 | $22.24 | $22.36 | $22.15 | 54,608 | 08-31-2018 |
$ | $22.40 | $22.48 | $22.54 | $22.40 | 64,565 | 08-30-2018 |
$ | $22.50 | $22.58 | $22.61 | $22.50 | 71,796 | 08-29-2018 |
$ | $22.53 | $22.46 | $22.54 | $22.41 | 83,380 | 08-28-2018 |
$ | $22.35 | $22.46 | $22.47 | $22.31 | 34,035 | 08-27-2018 |
$ | $22.15 | $22.25 | $22.32 | $22.15 | 77,663 | 08-24-2018 |
$ | $22.20 | $22.19 | $22.23 | $22.11 | 167,362 | 08-23-2018 |
$ | $22.22 | $22.25 | $22.28 | $22.17 | 61,188 | 08-22-2018 |
$ | $22.05 | $22.05 | $22.10 | $21.94 | 47,471 | 08-21-2018 |
$ | $22.03 | $21.95 | $22.04 | $21.94 | 36,321 | 08-20-2018 |
$ | $21.68 | $21.83 | $21.86 | $21.67 | 41,761 | 08-17-2018 |
$ | $21.54 | $21.59 | $21.71 | $21.54 | 63,129 | 08-16-2018 |
$ | $21.38 | $21.43 | $21.45 | $21.21 | 88,881 | 08-15-2018 |
$ | $21.57 | $21.55 | $21.57 | $21.48 | 102,213 | 08-14-2018 |
$ | $21.51 | $21.55 | $21.63 | $21.475 | 155,021 | 08-13-2018 |
$ | $21.55 | $21.51 | $21.59 | $21.43 | 46,066 | 08-10-2018 |
News, Short Squeeze, Breakout and More Instantly...
RELX N.V. American Depositary Shares (Each representing One) Company Name:
RENX Stock Symbol:
NYSE Market:
98% of 401 Primary Care Physicians confirmed KidneyIntelX has value as a risk decision tool in their adult patients with type 2 diabetes and chronic kidney disease stages 1-3b. Published study complements KidneyIntelX clinical utility data published at American Diabetes Associat...
NEW YORK and SALT LAKE CITY, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (LSE: RENX) (NASDAQ: RNLX) (“Renalytix” or the “Company”) today announced the company will be presenting at the upcoming 2021 Wells Fargo Virtual Healthcare Conference. Renaly...
NEW YORK and SALT LAKE CITY, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Renalytix Plc (NASDAQ: RNLX) (LSE: RENX) today announced the appointment of Daniel J. Levangie to the Company’s board of directors. Mr. Levangie is also appointed as a member of the Company’s remuneration commi...